Dr Vinil Kumar Bhuma, MD | |
802 Kenyon Rd, Fort Dodge, IA 50501-5740 | |
(515) 573-3101 | |
Not Available |
Full Name | Dr Vinil Kumar Bhuma |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 802 Kenyon Rd, Fort Dodge, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992937601 | NPI | - | NPPES |
201188630 | Medicaid | IN | |
000000843891 | Other | IN | BCBS MEMORAIL HOSPITALIST |
P01344459 | Other | IN | RR MEDICARE MEMORIAL HOSPITALIST |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 57218-20 (Wisconsin) | Secondary |
207Q00000X | Family Medicine | 01072960A (Indiana) | Secondary |
208M00000X | Hospitalist | 01072960 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Vinil Kumar Bhuma, MD 802 Kenyon Rd, Fort Dodge, IA 50501-5740 Ph: (515) 573-3101 | Dr Vinil Kumar Bhuma, MD 802 Kenyon Rd, Fort Dodge, IA 50501-5740 Ph: (515) 573-3101 |
News Archive
Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.
The human brain can recognize thousands of different objects, but neuroscientists have long grappled with how the brain organizes object representation; in other words, how the brain perceives and identifies different objects. Now researchers at the MIT Computer Science and Artificial Intelligence Lab (CSAIL) and the MIT Department of Brain and Cognitive Sciences have discovered that the brain organizes objects based on their physical size, with a specific region of the brain reserved for recognizing large objects and another reserved for small objects.
Enterprise Therapeutics Ltd today announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD001.
Corticosteroid anti-inflammatory drugs have been applied to COVID-19 patients over the course of the pandemic, though the results are mixed. In a recent study, the outcomes for such patients are collated, demonstrating a striking correlation between the development of autoantibodies and mortality.
› Verified 8 days ago
Mrs. Lisa June Carter, NP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 802 Kenyon Rd, Fort Dodge, IA 50501 Phone: 515-573-3101 |